Tackling bad cholesterol levels with statins may reduce dementia risk
Cholesterol-busting drugs have been linked to reducing the risk of dementia in a new study.
Statins are one of the most commonly prescribed drugs in the UK, with around seven to eight million people taking them to cut their chance of heart attack and stroke.
Now new research suggests they may have more benefits.
Experts found that people who have low levels of 'bad' cholesterol in their blood have a reduced risk of dementia, including Alzheimer's disease.
And use of statins was found to have 'additional protective effects'.
Statins are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood.
LDL cholesterol (LDL- C) is often referred to as 'bad cholesterol' and can cause plaque to build in arteries, leading to cardiovascular disease, which can increase the chance of strokes, heart attacks and death.
Are you aged over 40 and haven't had a cholesterol test in the past 5 years?
High cholesterol often doesn't have symptoms, but it can increase your risk of heart problems or stroke.
Take control of your health and get your cholesterol checked today! 💙#StrokePreventionDay pic.twitter.com/aEYVms6foA
— North East and North Cumbria NHS (@NENC_NHS) January 30, 2025
Researchers from South Korea said their findings 'underscore the crucial role of managing LDL- C in lowering dementia risk'.
Experts examined health data on more than 570,000 people in South Korea.
The NHS says that people should aim for bad cholesterol levels in the blood to be below 4mmol/L (millimoles per litre).
Researchers found that people whose LDL cholesterol levels were below 1.8 mmol/L had a 26% reduced risk of dementia and a 28% reduced risk in Alzheimer's compared to those who have LDL cholesterol levels above 3.4 mmol/L.
Statin use appeared to have additional protection against dementia in the presence of low LDL cholesterol levels.
Among people with LDL cholesterol levels below 1.8 mmol/L, statin use was linked to a 13% reduction in dementia risk and a 12% decrease in risk of Alzheimer's disease compared with non-users.
'These findings emphasise the importance of targeted LDL- C management as part of dementia prevention strategies, with potential integration into clinical guidelines,' the authors wrote in the Journal of Neurology Neurosurgery and Psychiatry.
'The results support the use of statin therapy within specific LDL- C ranges for both cardiovascular and cognitive health benefits.'
They added: 'This insightful understanding of how statin use interacts with LDL- C levels emphasises the need for personalised statin prescriptions, focusing on achieving LDL- C levels that offer the maximum cognitive benefits.'
Commenting on the study, Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'This large study looked at patient records for levels of LDL cholesterol and the risk of dementia, it also examined those patients who were on statins.
'It found that those people with lower LDL levels had a reduced risk of dementia.
'The use of statins seemed to offer a protective effect – even in those who already had cholesterol levels within a lower range.
'However, dementia risk is complex and influenced by many factors. Without a detailed picture of what's going on in the brain we do not know if there is a direct link between lower cholesterol and reduced dementia risk. Clinical trials will be key to understand what effects statins might be having on disease processes in the brain.
'In the meantime, keeping our hearts healthy remains one of the most effective ways we can protect our brain health. If you have any concerns about your cholesterol levels, you should speak to your GP.'
Dr Richard Oakley from the Alzheimer's Society added: 'Dementia risk is complicated and determined by several factors including genetics, lifestyle, and the environment.
'This study adds to our understanding by showing the strong connection between heart and brain health. Simply put, what is good for the heart is good for the head.'
He added: 'This is an ever-evolving topic, and more targeted research and trials are needed to understand whether statins can help protect the brain. However, it is crucial to talk to your GP before making any changes to your medication'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Tips to take care of your brain for Alzheimer's and Brain Health Awareness Month
June is Alzheimer's and Brain Health Awareness Month and people hoping to spread that awareness said there are things you can do to take charge of your brain health. Brain changes that cause Alzheimer's can begin 20 years or more before symptoms appear. Work to start on Rockdale Road next week Doing things like exercising, eating right, getting good quality sleep, and controlling blood pressure can improve brain health and reduce the risk of cognitive decline. While age and family history are factors, these can naturally help you to reduce your risk. Millcreek man says over $1000 was stolen from EBT account 'It's not just the individual with the diagnosis, but it's the over 480 thousand caregivers here in the state of Pennsylvania that are providing that care. It's the family members that are in that circle of care who need that information and support. We want people to know they're not alone,' said Sara Murphy, vice president of programs and services for the Alzheimer's Association Greater PA Chapter. Early detection of cognitive diseases is crucial. The Alzheimer's Association also has a help line that anyone can call to get support at 1-800-272-3900. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
6 hours ago
- Yahoo
Patients may be seen by any dental surgery
Patients could be moved around dental surgeries under proposed changes to the system. Instead of having a regular surgery, the changes could see people offered treatment at any practice within their health board area, with check-ups for those with healthy teeth pushed to every 18 to 24 months. The Welsh government said the proposals would improve access to dental services, particularly for those most in need. But the British Dental Association (BDA) said the opposite could happen and more patients may be forced to go private. The biggest change would see all patients over 18 placed onto a central waiting list, called the Dental Access Portal (DAP). They would then be allocated a surgery, which could be anywhere within the health board area. If they need treatment, they would remain with that surgery until it is complete and beyond, if they needed close monitoring. If or when teeth are healthy, patients would be returned to the central portal and would be recalled for a check-up in 18 to 24 months wherever there is space. Children would be assessed under the plans but stay at the first surgery they are allocated. Some charges for patients would also change - with check-ups going up from £20 to £24.75 but a single crown going down from £260 to £239.15. 'There could be no NHS dentists in two years' Welsh dentistry 'no example' to England Family unable to see a dentist in four years Health Minister Jeremy Miles said the plans would benefit everyone. "It will make NHS dentistry more attractive to dentists and that is good for patients," he said. "Actually, what we want to make sure is that patients do look after their own oral health but when they do need to see a dentist they will be able to access one which is the critical thing." Jody Pegler, 46, from Pontllanfraith, Caerphilly county, who has been with his dentist in Newbridge for more than 30 years, said: "I have been coming here since I was a child. "It's nice to see the same person on a regular basis." Mr Pegler, who has cerebral palsy and uses a wheelchair, said his family members needing to visit different surgeries could be problematic. "My wife, my child and myself could potentially be attending different practices," he said. "It's difficult to get out and to go anywhere really and if we have to go to different practices it would be impossible. "This dentist's in particular have made a big effort to make sure the practice is wheelchair accessible for me - that means a lot." Jody's dentist is Dr Harj Singhrao, owner of Newbridge Dental Care, who believes the potential breakdown in continued care will be "devastating". "If families can't be seen at the same practice, if people are punished then to join a waiting list because they have looked after their mouth, then where are they going to go? Because we know hospital waiting lists don't work," he said. The proposals are now part of a public consultation, open until 19 June, and in Cardiff people gave a mixed response to the plans when asked by BBC Wales. Robyn Weldon, 21, said: "I've been going to my dentist since I was probably six so I guess that would be a bit sad if I can't go to him. "I would say too that things haven't been going very well for the NHS so maybe this could be a good start to kind of make things easier for them and for us." Paul McCarthy, 77, said he was unaware of the changes. "I wouldn't be very happy about it either," he said. "I've been coming here for over 30 years and I'm used to coming here so I wouldn't like that at all." Justin Rees, 52, from Barry, Vale of Glamorgan, thought the new portal idea could be positive. "It's good because one, there are no appointments at the moment. "Two, it'll remind people that they need to have their teeth checked because you're busy all day and there's things that you let go," he said. In relation to how people currently access services, the consultation document says "contrary to popular belief" patients are not actually registered with a practice once their treatment ends, adding "for those who clinically require regular access, or an urgent need arises, nothing really changes". On check-ups, it says there is "false narrative" that six-monthly check-ups are necessary for everyone and that by giving people with healthy teeth a check-up less often, it will open up access for others. NICE guidelines say intervals between check-ups "should be determined specifically for each patient" and the longest interval for adults should be 18-24 months. But Dr Lauren Harrhy from the BDA said she was concerned that people may end up waiting much longer, with "most people" benefiting from regular checks. Dr Harrhy, who runs a practice in Pontypool, Torfaen, said: "If we are always having patients into the practice who need lots of work done and they are not able to be put back into the central database, there is a saturation point and at which point, access into dental practices will cease. "Our main concerns are we will have an overall reduction in the continuity of care... and we may find that dentists leave NHS dentistry which has been a trend over recent years anyway." Dentists also say the proposals offer no extra money to fund the changes. But Miles said investment in dentistry had increased year on year. "This isn't a contract we have drawn up from thin air, it is based on years worth of work, it's 13 months of negotiations with the BDA itself," he said. "No contract gives everybody exactly what they want but I am absolutely confident that for everybody - for patients, for dentists, for the NHS, for the government - this is a step forward." British Dental Association Why can't I find an NHS dentist in Wales? Fees will see more people pull teeth out - dentist Patient, 73, has 100-mile round trip for dentist
Yahoo
10 hours ago
- Yahoo
Blood test for Alzheimer's could soon be available on the NHS
A new blood test for Alzheimer's disease has been found to accurately detect early symptoms of the illness, according to new research. Experts from the Mayo Clinic in the US examined two proteins in blood plasma – amyloid beta 42/40 and p-tau217 – which are associated with amyloid plaque build-up, a hallmark of Alzheimer's disease, to provide further evidence that blood tests can accurately diagnose dementia. The study, which was carried out on more than 500 people in an outpatient memory clinic, found the blood test was highly accurate, with 95 per cent sensitivity. That means it was 95 per cent accurate in picking up people with memory problems, with very few cases missed. It was also 82 per cent for specificity, meaning it was also highly accurate in ruling out people without dementia. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US – we hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40, and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting.'
